Address:
Uskudar Icerenkoy Yolu Cad. No:21
Atasehir, Istanbul 34752
TURKIYE
Working Hours:
Monday - Friday: 9:00 - 18:30
Weekends: Closed

Biotechnology patents in Turkey have become increasingly significant as the life sciences sector continues to expand globally and domestically. The rapid development of pharmaceutical innovations, genetic engineering technologies, medical diagnostics, and agricultural biotechnology has heightened the need for robust intellectual property protection. Within this evolving legal and technological landscape, understanding the regulatory framework governing biotechnology patents in Turkey is essential for innovators, research institutions, and commercial enterprises seeking to safeguard their inventions.
As Akkas & Associates Law Firm, a leading full-service intellectual property law firm based in Istanbul, Turkey, we provide comprehensive legal guidance on securing and enforcing biotechnology patents. With extensive experience in Turkish patent law and a deep understanding of international patent standards, our firm assists clients in navigating complex patentability criteria, regulatory compliance, and strategic portfolio management.
Table of Contents
Biotechnology patents in Turkey are regulated primarily under Industrial Property Law No. 6769, which harmonizes national legislation with international agreements such as the European Patent Convention and the TRIPS Agreement. The Turkish Patent and Trademark Office (TURKPATENT) administers patent applications and evaluates compliance with statutory requirements.
Under Turkish patent law, biotechnology inventions must satisfy the standard patentability criteria of novelty, inventive step, and industrial applicability. However, biotechnology innovations often present unique legal challenges due to ethical considerations, biological materials, and the intersection between scientific discovery and patentable invention.
The legal framework recognizes that biological material isolated from its natural environment or produced through technical processes may be patentable, provided the invention demonstrates a clear technical contribution. This includes microorganisms, genetic sequences, and biotechnological processes that produce tangible industrial results.

To secure biotechnology patents in Turkey, applicants must demonstrate that their invention is new, involves an inventive step, and is capable of industrial application. These requirements are assessed rigorously, particularly for biotechnology-related claims involving biological substances.
Novelty requires that the invention has not been disclosed anywhere in the world before the filing date. For biotechnology inventions, this includes prior publication of genetic sequences, experimental methods, or biological processes.
Inventive step requires that the invention is not obvious to a person skilled in the art. In biotechnology contexts, this often involves demonstrating unexpected technical effects or innovative applications of known biological materials.
Industrial applicability requires that the invention can be produced or used in an industry such as pharmaceuticals, agriculture, or medicine. This criterion ensures that purely theoretical discoveries without practical use cannot be patented.
The scope of protection provided by biotechnology patents in Turkey extends to biological materials, manufacturing processes, and applications derived from patented inventions. Patent claims must be drafted carefully to define the extent of protection while satisfying disclosure requirements.
Protection may cover gene sequences, recombinant DNA technologies, cell cultures, vaccines, and diagnostic methods, provided the invention meets legal standards. The description must clearly disclose the biological material and its function, enabling replication by a skilled professional.
Biological materials, including microorganisms and genetic sequences, may be protected if isolated through technical means. However, naturally occurring substances as such are not patentable unless a technical process transforms them into a patentable invention.
Applicants must also disclose the industrial application of gene sequences to meet patentability requirements. The mere discovery of a DNA sequence without specifying its function or utility is generally insufficient.
Where an invention involves biological material that cannot be sufficiently described in writing, Turkish patent law allows the deposit of the material with recognized international depositary institutions under the Budapest Treaty. This ensures that the invention can be reproduced while maintaining confidentiality during the patent application process.





Despite broad protection for biotechnology innovations, certain subject matter is excluded from patentability due to ethical and public policy considerations. Turkish patent law reflects European standards in this regard.
Non-patentable subject matter includes human cloning processes, modification of the germline genetic identity of humans, and uses of human embryos for industrial or commercial purposes. Additionally, plant and animal varieties and essentially biological processes for their production are generally excluded, although microbiological processes may remain patentable.
These exclusions aim to balance technological advancement with ethical standards and public interest.
The process for obtaining biotechnology patents in Turkey involves several stages, including filing, formal examination, publication, substantive examination, and grant. Due to the technical complexity of biotechnology inventions, applications require detailed specifications and precise claim drafting.
Applicants must submit a detailed description of the invention, claims defining the scope of protection, drawings where applicable, and an abstract. For biotechnology inventions, the description must disclose the biological material sufficiently to enable reproduction.
The application may be filed directly with TURKPATENT or through international routes such as the Patent Cooperation Treaty (PCT) or the European Patent system, with subsequent validation in Turkey.
During substantive examination, patent examiners assess novelty, inventive step, and industrial applicability. Biotechnology applications often undergo rigorous scrutiny due to the specialized scientific nature of the subject matter.
Professional assistance from experienced Turkish patent attorneys is crucial at this stage to address examination reports and ensure compliance with legal standards.
Enforcement mechanisms play a critical role in protecting biotechnology patents in Turkey. Patent holders have the right to prevent unauthorized production, use, sale, or importation of patented biotechnology inventions.
Infringement actions may be initiated before specialized intellectual property courts, which handle disputes involving patent validity and enforcement. Remedies may include injunctions, damages, and seizure of infringing goods.
Effective enforcement requires strategic litigation planning and technical expertise. Patent owners must demonstrate the existence of a valid patent and evidence of infringement. Expert opinions and scientific analyses often play a decisive role in biotechnology patent disputes.
Courts may grant preliminary injunctions to prevent ongoing infringement, particularly where continued use of the patented technology could cause irreparable harm.
Turkey’s alignment with international intellectual property systems facilitates cross-border protection of biotechnology inventions. Companies operating globally often seek patent protection in multiple jurisdictions, making international coordination essential.
Biotechnology patents in Turkey can be integrated into broader patent strategies through the European Patent Office or PCT applications. This enables innovators to secure protection across several markets while maintaining compliance with national regulations.
Turkey’s patent regime reflects significant harmonization with European legal standards, particularly regarding biotechnology inventions. This alignment enhances legal predictability for international investors and research organizations seeking patent protection in Turkey.
Biotechnology patents in Turkey play a crucial role in promoting scientific research, technological development, and economic growth. Strong patent protection encourages investment in pharmaceutical development, agricultural innovation, and medical technologies.
Universities, research institutions, and biotechnology companies increasingly rely on patent protection to commercialize discoveries and maintain competitive advantage. Effective patent strategies also facilitate licensing agreements and technology transfer.
Patent protection enables innovators to license biotechnology inventions, attract venture capital investment, and establish strategic partnerships. The commercialization of biotechnology innovations contributes significantly to public health and industrial advancement.
A robust patent portfolio enhances market position and provides legal certainty for investors and collaborators.
Despite a comprehensive legal framework, applicants may face challenges when seeking biotechnology patents in Turkey. These challenges include complex patentability assessments, disclosure requirements, and ethical limitations.
Biotechnology inventions often involve interdisciplinary scientific fields, requiring applicants to provide detailed technical explanations and supporting data. Failure to meet disclosure standards may result in rejection or limited protection.
Ethical restrictions and public policy considerations significantly influence biotechnology patentability. Applicants must ensure compliance with legal exclusions while demonstrating the technical and industrial value of their inventions.
Professional legal guidance is essential to navigate these complexities and maximize the likelihood of successful patent registration.

The involvement of qualified Turkish patent attorneys is essential for drafting applications, managing prosecution procedures, and enforcing patent rights. Biotechnology inventions require specialized expertise in both legal and scientific fields.
Experienced patent professionals assist clients in preparing technical documentation, responding to examination reports, and developing strategic patent portfolios. Their role is particularly important in biotechnology cases involving complex biological data and regulatory requirements.
Professional representation also enhances the effectiveness of enforcement actions and dispute resolution.

Biotechnology patents in Turkey protect inventions involving biological materials, genetic sequences, microbiological processes, and biotechnological products that meet patentability requirements. These patents grant exclusive rights to the patent holder to prevent unauthorized use, production, or commercialization of the invention. Protection typically extends to the biological material itself, the process for producing it, and its specific applications.
Genetic sequences may be patentable under biotechnology patents in Turkey if they are isolated through technical processes and their industrial application is clearly disclosed. Turkish patent law requires that the function and practical use of the sequence be specified. Mere discovery of a naturally occurring gene without technical contribution is not patentable.
Biotechnology patents in Turkey generally provide protection for twenty years from the filing date, subject to payment of annual maintenance fees. During this period, the patent holder has exclusive rights to exploit the invention commercially and prevent unauthorized use.
The primary challenges include demonstrating novelty and inventive step, meeting strict disclosure requirements for biological materials, and complying with ethical restrictions. Biotechnology inventions often require extensive technical documentation and scientific evidence to support patent claims.
Patent holders may enforce biotechnology patents in Turkey through infringement actions before specialized intellectual property courts. Legal remedies include injunctions, damages, and seizure of infringing products. Enforcement typically requires technical evidence and expert analysis.
Professional assistance from Turkish patent attorneys ensures accurate drafting of applications, effective prosecution before the patent office, and strong enforcement strategies. Biotechnology inventions involve complex legal and scientific considerations that require specialized expertise.
Akkas & Associates Law Firm is a premier, full-service intellectual property law firm headquartered in Istanbul, Turkey, with over three decades of comprehensive IP law expertise dating back to 1992.
Selcuk Akkas, Attorney at Law, Patent & Trademark Attorney & Mediator
At Akkas & Associates Law Firm, we provide comprehensive legal services for biotechnology patents in Turkey, guiding clients through every stage of the patent lifecycle from initial filing to enforcement and portfolio management.
Our firm combines decades of experience in Turkish patent law with deep technical understanding of biotechnology innovations, enabling us to deliver tailored legal strategies that protect and maximize the value of our clients’ intellectual property assets. We assist multinational corporations, research institutions, startups, and individual inventors in securing robust patent protection aligned with their commercial objectives.
If you are seeking reliable legal support for biotechnology patents in Turkey, our experienced team of Turkish patent attorneys offers strategic counsel, technical expertise, and effective representation before TURKPATENT and intellectual property courts. We are committed to safeguarding innovation and helping clients navigate complex patent regulations with confidence. Contact Akkas & Associates Law Firm today to discuss your biotechnology patent needs and develop a comprehensive intellectual property strategy.